2. 5 CFT, 100 CFT and 300 CFT blenders that
will allow CPS to meeting a greater
range of batch size requests.
Additional features of these clean
rooms include sanitary mills, slant
cone mills, tumblers and packaging
stations, all of which can be configured to a
client’s specific needs.
* This expansion provides application coverage for a number of segments requiring
cGMP-compliant production, including personal care items,
food grade products, pharmaceutical excipients, active pharmaceutical ingredients and even controlled substances such
* The entire facility was designed to handle up to nine more
clean rooms in the future.
Additionally, recent investments in various sizes of spiral
style mills will allow for expanded pharmaceutical level
micronizing. This means CPS can offer batch sizes as
small as 10-50 grams, and as large as several metric tons.
Other production and quality assurance-oriented invest-
A Biokill Heat Screw unit that breaks down microbiological
agents to ensure products are safe for pharmaceu-
tical use. This gives CPS an opportunity to take
materials that may be considered
technical grade and clean them to
the point that they are acceptable as
A stainless steel air classifier that pro-
vides a second step after micronizing to fine
tune any desired particle range, if required. This
system can remove any coarse materials so the prod-
uct being packaged will meet more exacting specifications.
These investments not only allow for handling trial and production runs of various sizes and quantities, but the new facility has also expanded testing and R&D functions that include
cleaning and process validation. CPS feels that this range of
production capabilities and end-product services allows them
to cater to a customer’s specific needs in building a more personal relationship.
Along with investments in new production capabilities,
CPS has looked to improve the quality of their operational
processes. With this in mind the company recently unveiled
a new safety system that is being applied to pharmaceutical
grade products as part of the GMPs that are used on a daily
basis. This includes a revised HACCP plan to ensure no foreign contaminants reach end-products, and all facilities now
fall under a current ISO 9001 Quality Management System.
CPS feels that this shows that they’re not only meeting, but
exceeding customer requirements.
So as CPS looks to the future, they see opportunity in the
changes that lie ahead. The constantly evolving needs of
the pharmaceutical industry, in terms of new formulas, processes and regulations, means this contract manufacturer
will need to continue to evolve and invest in order to keep
pace. Their new facility and recent production equipment
investments help reinforce that commitment. ■